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Introduction
Depending on their stage of development or differentiation, B cells express specific chemokine receptors enabling them to respond to chemokines which control homing to the bone marrow (BM) and secondary lymphoid organs. [1] [2] [3] Here they are provided with signals crucial for progression through the consecutive stages of B cell development and differentiation. The chemokine stromal cell-derived factor-1 (SDF-1, also known as CXCL12)
plays an important role in lymphocyte trafficking. SDF-1, originally identified as a growthstimulatory factor for pre-B cells, 4 is constitutively expressed by BM stromal cells. [5] [6] [7] Its cognate receptor, the seven-transmembrane G-protein-coupled receptor CXCR4, is broadly expressed by cells of the immune system and mediates SDF-1-induced migration of hematopoietic progenitors and lymphocytes. [1] [2] [3] 8, 9 In the B cell lineage, CXCR4 is prominently expressed by pre-B cells and controls localization in cellular niches in the BM obligatory for B cell development. 3, 8 Furthermore, CXCR4 expression by mature B cells is required for proper germinal center organization, which is essential for antigen-specific B cell differentiation. 10 In addition, SDF-1 controls plasma cell migration, 6 and plasma cells require CXCR4 expression to localize in the BM compartment.
11,12
Multiple myeloma (MM), an incurable hematological malignancy with a median survival of 3-4 years, is characterized by the expansion of malignant plasma cells in the BM.
These tumor cells also express CXCR4, 13 and SDF-1 controls their α4β1-mediated adhesion to VCAM-1, fibronectin and endothelial cells, as well as their transendothelial migration and homing/retention in the BM tumor microenvironment. [13] [14] [15] [16] [17] [18] [19] MM cells are critically dependent on the BM microenvironment, where cytokines produced by BM stromal cells provide them with proliferation and survival signals required for their expansion. 16 Thus, by controlling homing and retention of MM cells in the BM, SDF-1 plays an important role in the pathogenesis of MM.
only.
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The important role of chemokine-induced migration in B cell development and differentiation, as well as in the pathogenesis of MM, prompted us to explore the underlying signaling pathways. Recently, we have established an important role for Bruton's tyrosine kinase (Btk) and phospholipase C-γ2 (PLCγ2) in chemokine-induced integrin-mediated migration and homing of B cells. 20 Importantly, however, Btk is not expressed in plasma cells and MM cells. [21] [22] [23] Several members of the Ras superfamily of small GTPases have also been implicated in chemokine-controlled B cell migration. [24] [25] [26] [27] This includes members of the Rho family 24, 25 and members of the Ras family, like Ras and Rap1. 26, 27 Ral, another member of the Ras family of small GTPases, has been shown to mediate a wide variety of cellular responses, including regulation of cytoskeletal rearrangements and cell motility. 28 Ral can bind to and regulate the activity of phospholipase D1, 29 the Sec5 and Exo84 subunits of the exocyst complex, 30,31 the actin binding protein filamin, 32 and the Cdc42/Rac GTPaseactivating protein Ral binding protein-1 (RalBP1). 33, 34 Notably, accumulating evidence indicates that Ral is an essential mediator of Ras-induced transformation of human cells. [35] [36] [37] [38] Interestingly, Ral is involved in invasion and metastasis of transformed cells and in Ras-and growth factor-controlled cell migration; [39] [40] [41] [42] [43] [44] [45] [46] [47] however, thus far a role for Ral in chemokinecontrolled signaling and migration has not been described. Here we show that Ral is activated in response to SDF-1 and mediates SDF-1-induced chemotaxis of B cells and MM cells.
Materials and Methods

Materials
Monoclonal antibodies used were: mouse anti-RalA (IgG2a), anti-Rap1 (IgG1), biotinylated rat anti-mouse CXCR4 (2B11/CXCR4) (all BD Biosciences), and Streptavidin-PE (Southern Biotechnology Associates). Polyclonal antibodies used were: rabbit anti-RalB (BD , respectively.
Isolation of primary cells and cell culture
Human tonsillar B cells were isolated essentially as described previously. 51 The Netherlands). The chicken bursal lymphoma cell line DT40 were cultured at 39,5°C as described. 48 Stable overexpression of RasN17 in DT40 cells was performed by electroporation, using the pA-puroII-RasN17 expression vector (kindly provided by Dr. T.
Kurosaki), exactly as described.
55
Ral and Rap pull-down assays
Cells were resuspended in RPMI or IMDM to 2.0 x 10 7 cells/ml and stimulated with SDF-1 (100 ng/ml). Reactions were terminated by adding an equal volume of cold 2 x lysis buffer (100 mM Tris-HCl pH 7.4, 400 mM NaCl, 5 mM MgCl 2 , 2% Nonidet P-40, 20% glycerol, 2 x EDTA-free protease inhibitor cocktail tablets (Roche) per 50ml). After 10 minutes on ice, 
Cell adhesion assay
Adhesion assays were performed in triplicate on flat-bottom, high binding 96-well plates (Costar) coated overnight at 4° C with PBS containing 1 µg/ml sVCAM-1 and 4% BSA, with or without 150 ng/ml SDF-1, and then blocked for 1 h at 37° C with 4% BSA in RPMI 1640.
1.5 x 10 5 cells were plated in 100 µl/well RPMI containing 1% BSA, spun down briefly (6000 rpm, 30 s) and incubated at 37° C for 2 min. After extensive washing of the plate with RPMI containing 1% BSA to remove nonadhering cells, the adherent cells were lysed and Renilla luciferase activity was determined according to manufacturer's instructions (Dual-Luciferase only.
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Immunoblotting
Immunoblotting was performed essentially as previously described. 51 Quantification was performed using Image-Pro plus (MediaCybernetics) software.
Statistical analysis
The unpaired two-tailed Student's t test was used to determine the significance of differences between means. All relevant comparisons were significantly different (P < 0.05), unless otherwise indicated. 
Results
SDF-1 induces migration and Ral activation in B cells and MM cells
Ral mediates SDF-1-induced migration of B cells and MM cells
To investigate whether Ral mediates SDF-1-induced B cell migration, we generated DT40 cells stably expressing a dominant negative Ral mutant, RalN28, which prevents SDF-1- only.
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RalB rather than RalA mediates SDF-1-induced MM migration
Mammalian cells can express two isoforms of Ral, RalA and RalB, which show 85% identity.
Although these proteins are highly similar, they appear to have different functions. Whereas
RalA is an essential mediator of Ras-controlled tumorigenesis, RalB has shown to be involved in tumor cell motility. 37, 46 To determine which Ral isoform is involved in SDF-1-induced MM migration, OPM-1 and NCI-H929 were transiently transfected with a GFP construct and constructs expressing short-hairpin RNA (shRNA) directed against either RalA, RalB or, as a control, renilla. In OPM-1 cells, and to a lesser extent NCI-H929 cells, these constructs were found to efficiently knock down expression of RalA or RalB, respectively ( Figure 4A ).
Notably, however, expression of RalA shRNA also resulted in decreased anti-RalB signal, and vice versa ( Figure 4A ), indicating that although these antibodies display isoform preference, they are not strictly specific. This was confirmed by the observation that the antiRalB antibody also detects ectopically expressed RalA (data not shown). Interestingly, MM cells transfected with shRNA against RalB showed impaired migration towards SDF-1, whereas only a modest or no decrease in migration was observed in cells with reduced RalA expression ( Figure 4B ). Furthermore, among the MM cell lines there appears to be a correlation between the efficiency of RalB silencing and the suppression of migration. Taken together, our data suggest that SDF-1-induced MM cell migration is predominantly mediated by RalB. Figure   5B ); however, these pharmacological inhibitors did not affect SDF-induced Ral activation either ( Figure 5B ). Figure 5C ).
SDF-1-induced Ral activation is independent of Lyn
Taken together, these data demonstrate that activation of Ral is required but not sufficient for full SDF-1-induced migration, and SDF-1-induced activation of Ral and Ralmediated migration occurs independent of the established migration-regulatory pathways involving Lyn/Syk, Btk, PLC, PI3K or Ras.
Discussion
We C3 treatment impairs SDF-1-induced MM cell adhesion to VCAM-1 and fibronectin. 15 Interestingly, C3 was also found to bind with high affinity to GDP-bound Ral GTPases. 76,77 C3 binding to Ral stabilizes the GDP-bound, inactive conformation, and as a consequence C3
interferes with Ral signaling. 77 Moreover, by binding of C3 to Ral, the ribosylation and inactivation of Rho is blocked. 76, 77 This can be overcome by increasing the C3 concentration, 76 suggesting that C3-mediated inactivation of Rho only occurs after all Ral proteins have been inhibited. Therefore effects of C3 which are ascribed to Rho inactivation could also be due to inhibition of Ral.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From Ral might regulate chemokine-controlled migration in various manners. Ral GTPases may control chemotaxis by modulating the actin cytoskeleton through interaction with the Cdc42/Rac GTPase-activating protein RalBP1. 33, 34 . In addition, RalA can control filopodia formation by recruitment of the Ral-effector complex the exocyst 78 and the actin filament cross linking protein filamin, 32 which can affect migration. However, RalB rather than RalA was found to mediate MM cell chemotaxis ( Figure 5B ). Similarly, specifically RalB was recently shown to be involved in cancer cell motility. 46, 47 By recruiting the exocyst, RalB is believed to control the coordinated delivery of secretory vesicles to the sites of dynamic plasma membrane expansion that specify directional movement. 47 The differential requirement for Ral isoforms in cell migration might be the consequence of differences in the C-terminal variable regions of RalA and RalB. Due to their different C-termini, RalA and RalB localize to different subcellular compartments, which determines their specific functions. 37, 79 In addition, despite the high degree of effector-binding domain sequence homology, the affinity for effectors varies between the two Ral isoforms. 79 Previously, Battacharya et al. found that Ral is involved in fMLP-induced cytoskeletal reorganization. 71 In this study, the RalGEF RalGDS was found to be activated by β-arrestins in a Ras-independent manner. Interestingly, β-arrestins are important mediators of G-proteincoupled receptor signaling, 80 and are required for CXCR4-mediated lymphocyte chemotaxis. 81 β-arrestin-mediated SDF-1-induced chemotaxis was found to be mediated by the p38 MAPK, 82 a signaling molecule activated by Ral in growth factor signaling. 83 Combined with our observation that SDF-1 induces Ral activation independent of Ras activity ( Figure 5C ), it is tempting to speculate that SDF-1 activates Ral via β-arrestins, which may lead to p38-mediated chemotactic responses. JNK, another MAPK, was also found to be involved in B cell chemotaxis, 84 and in mediating several Ral-dependent processes, including tissue development, 85 protection against oxidative stress, 86 and survival of tumor cells. 38 only.
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